Cresud S.A.C.I.F. y A. CRESY
12.71
(0.03)
(0.24%)
as of 25 Sep
- Market cap
- $903.7M
- P/E
- 5.4×
Follow CRESY
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
7.14 | 3.40 | 3.77 | 5.37 |
P/S ratio |
0.69 | 0.59 | 0.87 | 0.90 | |
P/FCF ratio |
4.80 | 2.33 | 3.34 | 4.92 | |
P/Operating CF |
4.19 | 4.50 | (14.98) | (22.06) | |
P/B ratio |
0.28 | 0.27 | 0.43 | 0.41 | |
Price to Tangible BV |
0.29 | 0.27 | 0.44 | 0.42 | |
EV/Sales |
1.04 | 0.93 | 1.34 | 1.37 | |
EV/EBITDA |
4.01 | 1.33 | 2.10 | 3.51 | |
EV/Operating CF |
6.29 | 3.52 | 5.03 | 6.85 | |
EV/FCF |
7.28 | 3.63 | 5.15 | 7.52 | |
Quick Ratio |
0.93 | 1.01 | 1.07 | 1.05 | |
Current Ratio |
1.24 | 1.33 | 1.43 | 1.43 | |
Net Debt/EBITDA |
1.59 | 1.41 | 23.89 | (5.23) | |
Debt/Assets |
15.87% | 17.37% | 21.29% | 19.78% | |
Debt/Equity |
0.36 | 0.40 | 0.52 | 0.46 | |
Asset Turnover |
0.15 | 0.21 | 0.21 | 0.21 | |
Operating CF/Net income |
1.87 | 4.12 | (2.17) | (1.31) | |
Capex/Depreciation |
(1.52) | 0.84 | 2.69 | (4.07) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
27.95% | 18.41% | 20.22% | 27.51% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(2.59) | (2.77) | (1.88) | (1.78) | |
Graham Number |
34.99 | 44.40 | 46.89 | 40.51 | |
Earnings Yield |
14.00% | 29.40% | 26.52% | 18.63% | |
Free Cash Flow Yield |
20.83% | 42.85% | 29.96% | 20.33% | |
Revenue per Share |
4.36 | 4.19 | 3.44 | 2.76 | |
Operating CF per Share |
2.51 | 2.00 | (0.84) | (0.58) | |
Capex per Share |
(0.16) | 0.05 | 0.14 | (0.29) | |
Free Cash Flow per Share |
2.35 | 2.04 | (0.70) | (0.87) | |
Cash per Share |
8.09 | 8.33 | 8.19 | 7.35 | |
Shareholders Equity per Share |
37.02 | 33.19 | 29.17 | 30.77 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
37.02 | 33.19 | 29.17 | 30.77 | |
Free Cash Flow |
140.54 | 124.46 | (43.67) | (55.73) | |
Working Capital |
244.92 | 282.35 | 331.92 | 342.41 | |
Capital Expenditures |
(9.31) | 2.89 | 9.07 | (18.81) | |
Net Current Asset Value |
(1,628.33) | (1,514.83) | (1,487.97) | (1,450.19) | |
EV/EBIT |
4.31 | 1.37 | 2.16 | 3.69 | |
Capex to Sales |
0.04 | (0.01) | (0.04) | 0.11 | |
Net Profit Margin |
30.79% | 11.57% | 11.29% | 15.90% | |
Price to Operating Income |
2.84 | 0.88 | 1.40 | 2.41 | |
| Other line items | |||||
Average Receivables |
485.99 | 358.99 | 339.34 | 347.03 | |
Average Payables |
413.75 | 325.67 | 321.75 | 277.14 | |
Average Inventory |
334.37 | 233.62 | 256.49 | 278.59 | |
Average Assets |
6,017.52 | 4,370.36 | 4,387.16 | 4,357.43 | |
Average Common Equity |
2,670.80 | 1,923.16 | 1,825.36 | 1,841.14 |
Columns are period end dates